Xue X, Ren Z, Zhang A, Yang Q, Zhang W, Liu F (2016) Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials
People with obesity but not diabetes lost up to 24% of their initial body weight in 48 weeks
GLP-1 Agonists: A Growing Class of Medications GLP-1 agonists are a class of medications that mimic the action of glucagon-like peptide-1 (GLP-1) in our bodies
All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment
Other ways to help keep your skin healthier during GLP-1 treatment include: Eating lots of protein to help prevent muscle loss Protecting your skin with daily sunscreen Staying well-hydrated Using skincare products (such as retinoids) that encourage production of collagen to reduce wrinkles and sagging If youre still bothered by cosmetic side effects after achieving your goals, talk to your doctor about possible solutions
Growth hormone secretagogues (such as CJC-1295 and ipamorelin) act on the hypothalamic-pituitary axis to stimulate growth hormone release, whereas BPC-157 and TB-500 are associated with claims around tissue repair and recovery none of which are supported by robust human clinical data